Eicosapentaenoic acid (C20:5 omega-3) and docosahexaenoic acid (C22:6 omega-3), representative omega-3 PUFAs, have been observed to reduce hepatic lipidosis, improve markers of liver damage, and increase insulin sensitivity [31,32]. The gene discussed is INS; the disease is fatty liver disease.